Librax (Chlordiazepoxide, Clidinium Bromide)

Chlordiazepoxide binds to the GABA‑A receptor complex, enhancing the inhibitory effect of the neurotransmitter GABA. This results in reduced neuronal excitability, producing anxiolysis, muscle relaxation and sedation, which together help lessen the perception of gastrointestinal pain and associated stress.

The dosage of Librax is individualized and must be determined by a qualified prescriber based on the patient’s condition, age, renal and hepatic function, and response to therapy. Patients should follow the exact instructions provided on the prescription label.

Safety data for Librax during pregnancy and lactation are limited. The potential risks to the fetus or infant are not well defined, so healthcare professionals should weigh the benefits against possible harms and consider alternative therapies when appropriate.

To request Librax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternatives are single‑component antispasmodics such as dicyclomine or hyoscine. Unlike those agents, Librax combines a benzodiazepine with an anticholinergic, offering both central anxiolytic effects and peripheral smooth‑muscle relaxation, which can be advantageous for patients with significant anxiety‑related GI symptoms.

Librax tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container to protect them from moisture and light. Keep the medication out of reach of children and do not use if the packaging is damaged.

Librax is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to minimize gastrointestinal irritation.

Serious adverse reactions include severe respiratory depression, marked hypotension, paradoxical agitation, and life‑threatening allergic responses such as anaphylaxis. Patients should seek immediate medical attention if they experience difficulty breathing, extreme drowsiness, fainting, or signs of a severe allergic reaction.

Librax is contraindicated in patients with known hypersensitivity to chlordiazepoxide, clidinium bromide, or any component of the formulation. It should also be avoided in individuals with acute narrow‑angle glaucoma, severe hepatic impairment, or those who are dependent on benzodiazepines without proper medical supervision.